Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes

Author:

Takigawa Ken1,Shima Takahiro12ORCID,Kubara Chiaki1,Akamine Shun3,Utsumi Sae1,Yoshino Teruhiko1,Minami Mariko1,Hayashi Masayasu1,Matsuo Yayoi1,Kuriyama Takuro1,Yoneda Reiko3,Taniguchi Shuichi1,Eto Tetsuya1

Affiliation:

1. Department of Hematology Hamanomachi Hospital Fukuoka Japan

2. Department of Hematology Kyushu University Hospital Fukuoka Japan

3. Department of Pathology Hamanomachi Hospital Fukuoka Japan

Abstract

AbstractBackgroundPosterior reversible encephalopathy syndrome (PRES) is known as a transfusion‐related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce.Case ReportAn 88‐year‐old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin levels improved from 4.6 to 8.0 g/dL and the pleural effusions substantially decreased following six units of red blood cell transfusion and diuretic therapy, a gradual decline in cognitive function and speech reduction was noted. PRES was diagnosed by magnetic resonance imaging of the head. Despite treatment of intensive supportive care, the patient fell into a coma by the 20th day and passed away on the 22nd day. Although the pathophysiological link between blood‐transfusion‐related PRES and its impact on survival is not fully understood, autopsy findings confirmed the diagnosis of PRES and revealed multiple cerebral hemorrhages that were not detected in earlier imaging studies.ConclusionThis case highlights the importance of vigilant monitoring and management of PRES, especially in high‐risk populations such as elderly patients with multiple comorbidities or those with thrombocytopenia. Further studies are needed to elucidate the mechanisms of PRES in patients with hematologic diseases.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3